These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 30697755)

  • 21. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
    Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
    Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening.
    Brandt KR; Scott CG; Ma L; Mahmoudzadeh AP; Jensen MR; Whaley DH; Wu FF; Malkov S; Hruska CB; Norman AD; Heine J; Shepherd J; Pankratz VS; Kerlikowske K; Vachon CM
    Radiology; 2016 Jun; 279(3):710-9. PubMed ID: 26694052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
    Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
    Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammographic non-dense area and breast cancer risk in postmenopausal women: a causal inference approach in a case-control study.
    Velásquez García HA; Sobolev BG; Gotay CC; Wilson CM; Lohrisch CA; Lai AS; Aronson KJ; Spinelli JJ
    Breast Cancer Res Treat; 2018 Jul; 170(1):159-168. PubMed ID: 29516373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screen-detected versus interval cancers: Effect of imaging modality and breast density in the Flemish Breast Cancer Screening Programme.
    Timmermans L; Bleyen L; Bacher K; Van Herck K; Lemmens K; Van Ongeval C; Van Steen A; Martens P; De Brabander I; Goossens M; Thierens H
    Eur Radiol; 2017 Sep; 27(9):3810-3819. PubMed ID: 28289944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk.
    Giorgi Rossi P; Djuric O; Hélin V; Astley S; Mantellini P; Nitrosi A; Harkness EF; Gauthier E; Puliti D; Balleyguier C; Baron C; Gilbert FJ; Grivegnée A; Pattacini P; Michiels S; Delaloge S
    Sci Rep; 2021 Oct; 11(1):19884. PubMed ID: 34615978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiomic Phenotypes of Mammographic Parenchymal Complexity: Toward Augmenting Breast Density in Breast Cancer Risk Assessment.
    Kontos D; Winham SJ; Oustimov A; Pantalone L; Hsieh MK; Gastounioti A; Whaley DH; Hruska CB; Kerlikowske K; Brandt K; Conant EF; Vachon CM
    Radiology; 2019 Jan; 290(1):41-49. PubMed ID: 30375931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of a Four-View Mammographic Image Feature Based Fusion Model to Predict Near-Term Breast Cancer Risk.
    Tan M; Pu J; Cheng S; Liu H; Zheng B
    Ann Biomed Eng; 2015 Oct; 43(10):2416-28. PubMed ID: 25851469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can quantitative evaluation of mammographic breast density, "volumetric measurement", predict the masking risk with dense breast tissue? Investigation by comparison with subjective visual estimation by Japanese radiologists.
    Oiwa M; Endo T; Suda N; Morita T; Sato Y; Kawasaki T; Ichihara S
    Breast Cancer; 2019 May; 26(3):349-358. PubMed ID: 30387023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the feasibility of stratified breast cancer screening using a masking risk predictor.
    Alonzo-Proulx O; Mainprize JG; Harvey JA; Yaffe MJ
    Breast Cancer Res; 2019 Aug; 21(1):91. PubMed ID: 31399056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
    Krishnan K; Baglietto L; Stone J; McLean C; Southey MC; English DR; Giles GG; Hopper JL
    BMC Cancer; 2017 Dec; 17(1):859. PubMed ID: 29246131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography.
    Keller BM; Chen J; Daye D; Conant EF; Kontos D
    Breast Cancer Res; 2015 Aug; 17():117. PubMed ID: 26303303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of volumetric breast density on the risk of screen-detected and interval breast cancers: a cohort study.
    Wanders JOP; Holland K; Karssemeijer N; Peeters PHM; Veldhuis WB; Mann RM; van Gils CH
    Breast Cancer Res; 2017 Jun; 19(1):67. PubMed ID: 28583146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of synthetic mammography, reconstructed from digital breast tomosynthesis, and digital mammography: evaluation of lesion conspicuity and BI-RADS assessment categories.
    Mariscotti G; Durando M; Houssami N; Fasciano M; Tagliafico A; Bosco D; Casella C; Bogetti C; Bergamasco L; Fonio P; Gandini G
    Breast Cancer Res Treat; 2017 Dec; 166(3):765-773. PubMed ID: 28819781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast Imaging Reporting and Data System (BI-RADS) breast composition descriptors: automated measurement development for full field digital mammography.
    Fowler EE; Sellers TA; Lu B; Heine JJ
    Med Phys; 2013 Nov; 40(11):113502. PubMed ID: 24320473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
    Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
    J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AI performance by mammographic density in a retrospective cohort study of 99,489 participants in BreastScreen Norway.
    Bergan MB; Larsen M; Moshina N; Bartsch H; Koch HW; Aase HS; Satybaldinov Z; Haldorsen IHS; Lee CI; Hofvind S
    Eur Radiol; 2024 Oct; 34(10):6298-6308. PubMed ID: 38528136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial intelligence in BreastScreen Norway: a retrospective analysis of a cancer-enriched sample including 1254 breast cancer cases.
    Koch HW; Larsen M; Bartsch H; Kurz KD; Hofvind S
    Eur Radiol; 2023 May; 33(5):3735-3743. PubMed ID: 36917260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining quantitative and qualitative breast density measures to assess breast cancer risk.
    Kerlikowske K; Ma L; Scott CG; Mahmoudzadeh AP; Jensen MR; Sprague BL; Henderson LM; Pankratz VS; Cummings SR; Miglioretti DL; Vachon CM; Shepherd JA
    Breast Cancer Res; 2017 Aug; 19(1):97. PubMed ID: 28830497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.